Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 1471 days for 2019).
- 2025not filed
- 202419/09/2025
- 202325/10/2024
- 202225/10/2024
- 202125/10/2024
- 202025/10/2024
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
Industry
Authorized Representatives
Manner of representation
The company is represented, in the case of a one-person management board, by each member of the management board, whereas in the case of a multi-member management board, by the President of the Management Board independently, by two members of the management board acting jointly, or by one member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Rafał Paweł Młodawskiage 47 | 6,140 | $82,928.15 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
HAUSsp. z o.o. | 10,170.18 USD | 20.0639% |
Bank accounts
Registered as a VAT taxpayer on 2016-05-23.
78 1240 1040 1111 0010 8382 9951
02 1090 1883 0000 0001 4963 6807- 81 1240 1040 1111 0010 8556 0377
Debt
1 closed proceeding recorded in KRZ history.
| Registration date | Proceeding type | Status | |
|---|---|---|---|
| Mar 10, 2023 | Discontinued enforcement proceedings | Closed |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 1, 2017 | Aid for research and development projects: industrial research | $1.2M$1,160,133 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Dec 1, 2017 | Aid for research and development projects: experimental development | $512.5K$512,478 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| WPD Pharmaceuticalssp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-05-14 | Address change (Klonowa 46j, 05-830, Kajetany → Al. Aleje Jerozolimskie 81, 02-001, Warszawa) | |
| 2018-05-15 | Share capital increase (245,450.00 PLN → 307,000.00 PLN) | |
| 2017-08-18 | Address change (Ul. Czarnowiejska 6, 31-126, Kraków → Klonowa 46j, 05-830, Kajetany) | |
| 2017-08-18 | Share capital increase (5,000.00 PLN → 245,450.00 PLN) | |
| 2017-08-18 | PKD change (Removed: 9 codes; Added: 9 codes) |
FAQ
Last updated: 2026-10-07